$ 12.8 billion
Completed
24/7/2015
Kurt Stumpo - Journalist
United States
Acquisition finance
Investment grade bond/note issue
Public acquisition
Capital markets : Debt
M&A
United States
Pharmaceuticals and life sciences
Party: JP Morgan (Underwriter)
Party: Barclays (Underwriter)
Party: BofA Merrill Lynch (Underwriter)
Lawyer: Roxane Reardon